Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
出版年份 2015 全文链接
标题
Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
作者
关键词
-
出版物
Journal of Immunology Research
Volume 2015, Issue -, Pages 1-14
出版商
Hindawi Limited
发表日期
2015-10-24
DOI
10.1155/2015/308574
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- LBA15A PHASE 1B STUDY OF PEMBROLIZUMAB (PEMBRO; MK-3475) IN PATIENTS (PTS) WITH ADVANCED GASTRIC CANCER
- (2017) K. Muro et al. ANNALS OF ONCOLOGY
- Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor
- (2015) H Singh et al. CANCER GENE THERAPY
- The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
- (2015) Kathleen M. Mahoney et al. CLINICAL THERAPEUTICS
- The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
- (2015) Daniel Sanghoon Shin et al. CURRENT OPINION IN IMMUNOLOGY
- Immune Therapy in GI Malignancies: A Review
- (2015) Judy Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapid Eradication of a Bulky Melanoma Mass with One Dose of Immunotherapy
- (2015) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Epigenetics Meets Immune Checkpoints
- (2015) Alessia Covre et al. SEMINARS IN ONCOLOGY
- Gastric cancer and the epoch of immunotherapy approaches
- (2015) Elena Niccolai et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical Development of Immune Checkpoint Inhibitors
- (2015) Ayumu Ito et al. Biomed Research International
- The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
- (2015) Leisha A. Emens et al. Cancer Immunology Research
- The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors
- (2015) Emanuela Romano et al. Journal for ImmunoTherapy of Cancer
- Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy
- (2015) Weiguo Wang et al. Oncotarget
- Blockade of the B7-H1/PD-1 Pathway as a Basis for Combination Anticancer Therapy
- (2014) Mario Sznol CANCER JOURNAL
- Programmed death-1 pathway in cancer and autoimmunity
- (2014) Ariel Pedoeem et al. CLINICAL IMMUNOLOGY
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Interaction between gastric cancer stem cells and the tumor microenvironment
- (2014) Takatsugu Ishimoto et al. JOURNAL OF GASTROENTEROLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Checkpoint inhibitors in immunotherapy of ovarian cancer
- (2014) Dong-hui Wang et al. TUMOR BIOLOGY
- Immunotherapy in gastric cancer
- (2014) Satoko Matsueda WORLD JOURNAL OF GASTROENTEROLOGY
- Cancer immunotherapy in clinical practice��the past, present, and future
- (2014) Gaurav Goel et al. Chinese Journal of Cancer
- Immune checkpoints in cancer clinical trials
- (2014) Elad Sharon et al. Chinese Journal of Cancer
- Chimeric Antigen Receptor Therapy for Cancer
- (2013) David M. Barrett et al. Annual Review of Medicine
- Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions
- (2013) Amedeo Amedei et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy
- (2013) C. J. Nirschl et al. CLINICAL CANCER RESEARCH
- Coinhibitory molecules in cancer biology and therapy
- (2013) Simone Mocellin et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The enhanced effect of lupeol on the destruction of gastric cancer cells by NK cells
- (2013) Xiao-Ting Wu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
- (2013) Andrew M. Intlekofer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma
- (2012) Martina Mayr et al. BMC CANCER
- The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting
- (2012) S Kailayangiri et al. BRITISH JOURNAL OF CANCER
- Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine
- (2012) Masanori Noguchi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
- (2012) J. B. Mitchem et al. CANCER RESEARCH
- T Cells in Gastric Cancer: Friends or Foes
- (2012) Amedeo Amedei et al. Clinical & Developmental Immunology
- Increased apoptosis and elevated Fas expression in circulating natural killer cells in gastric cancer patients
- (2012) Hiroaki Saito et al. Gastric Cancer
- Immunotherapy for gastric premalignant lesions and cancer
- (2012) Valerio Zorzetto et al. Immunotherapy
- Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer
- (2012) TORU MASUZAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cancer Control in the Asia Pacific Region: Current Status and Concerns
- (2012) H.-R. Shin et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model
- (2012) XIAOHUI DU et al. ONCOLOGY REPORTS
- Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
- (2012) Ji Soo Park et al. Cancer Research and Treatment
- Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
- (2012) Dario Sangiolo Journal of Cancer
- Preparation and antitumor effects of nanovaccines with MAGE-3 peptides in transplanted gastric cancer in mice
- (2012) Jun Yang et al. Chinese Journal of Cancer
- Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
- (2011) R. J. Brentjens et al. BLOOD
- Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency
- (2011) J. H. Kim et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy
- (2011) Carlos A Ramos et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Novel Immunotherapeutic Strategies of Gastric Cancer Treatment
- (2011) Amedeo Amedei et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
- (2011) O. S. Qureshi et al. SCIENCE
- The tumor microenvironment
- (2011) Cynthia E. Weber et al. SURGICAL ONCOLOGY-OXFORD
- Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells
- (2010) Yeon Jin Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Successful Eradication of Established Peritoneal Ovarian Tumors in SCID-Beige Mice following Adoptive Transfer of T Cells Genetically Targeted to the MUC16 Antigen
- (2010) A. A. Chekmasova et al. CLINICAL CANCER RESEARCH
- Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma
- (2010) C. Ralph et al. CLINICAL CANCER RESEARCH
- Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN
- (2010) Jin Hee Kim et al. IMMUNOLOGY LETTERS
- Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity
- (2010) Caroline J Voskens et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
- (2010) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- R0 resection in the treatment of gastric cancer: Room for improvement
- (2010) Alberto Biondi WORLD JOURNAL OF GASTROENTEROLOGY
- Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma
- (2009) Amedeo Amedei et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer Immunotherapy: The Role Regulatory T Cells Play and What Can be Done to Overcome their Inhibitory Effects
- (2009) Ulf Petrausch et al. CURRENT MOLECULAR MEDICINE
- CD28 and CTLA-4 coreceptor expression and signal transduction
- (2009) Christopher E. Rudd et al. IMMUNOLOGICAL REVIEWS
- Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy
- (2009) Daniel Hollyman et al. JOURNAL OF IMMUNOTHERAPY
- Exuberated Numbers of Tumor-Specific T Cells Result in Tumor Escape
- (2008) O. Goldberger et al. CANCER RESEARCH
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
- (2007) Markéta Tomšová et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search